News

Drs. Anthony Fauci, Lee Hood Talk COVID-19, Vaccines, Future of Research, More

ISB’s Dr. Lee Hood presented the PMWC Luminary Award to Dr. Anthony Fauci on Monday, and the two renowned scientists engaged in an interesting hour-long conversation. 

The Luminary Award was presented on behalf of Precision Medicine World Conference on the first day of PMWC COVID, a three-day virtual event. The award recognizes contributions of prominent figures who have accelerated personal medicine to the clinic.

Hood spoke with Fauci, director of the National Institute of Allergy and Infectious Disease, about a number of topics, including the importance of basic research, the extraordinary speed of COVID research, the efficacy of mRNA vaccines on COVID-19 and the technology’s promise for creating effective vaccines for other diseases (including some cancers), lessons learned from the COVID-19 pandemic, and more. 

“We should have a vaccine, as well as universally applicable antivirals, that we could use for the next outbreak,” Fauci said. “I would be really disappointed if when this is over we don’t put together a commission and codify what we need to do as opposed to saying ‘well, we got through that, now let’s worry about the next problem’.”

You can watch the conversation here or by playing the video above.

Recent Articles

  • The Aging Microbiome

    Gut Microbiome Implicated in Healthy Aging and Longevity

    The gut microbiome is an integral component of the body, but its importance in the human aging process is unclear. ISB researchers and their collaborators have identified distinct signatures in the gut microbiome that are associated with either healthy or unhealthy aging trajectories, which in turn predict survival in a population of older individuals.

  • Priyanka Baloni

    Bile Acids Provide More Evidence of the Gut Microbiome’s Effect on Alzheimer’s Disease

    ISB researchers and their collaborators are looking beyond the one-drug, one-solution approach that has thus far failed in Alzheimer’s disease research. Instead, they are focusing on other promising research avenues, such as the possible role of the gut microbiome in dementia.

  • Overall composition of gut microbiome in participants

    Variations in the Microbiome Associated with Health, Disease

    ISB researchers examined the associations between the gut microbiomes of about 3,400 people and roughly 150 host characteristics. The team looked at diet, medication use, clinical blood markers, and other lifestyle and clinical factors, and found evidence that variations of the gut microbiome are associated with health and disease.